Recon: FDA adcomm gives thumbs up to GSK’s anemia drug; Italy alleges Pfizer hid $1.2B in profits
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy